Stocktoria

Structure Therapeutics Inc. GPCR

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2023-02-03

Structure Therapeutics Inc. statistics & valuation

Market cap$3.4B
P / B2.3×
Return on equity-9.3%
Return on capital-11.6%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2022202320242025
Operating margin (%)
2022202320242025
Return on equity (%)
-19.80% -14.20% -9.30% 2022202320242025
Shares outstanding
10.5M 139.2M 171.9M 212.5M 2022202320242025
Net debt ($)
2022202320242025
Share buybacks ($)
2022202320242025
Return on assets (%)
-52.50% -18.60% -13.60% -8.90% 2022202320242025
Free cash flow margin (%)
2022202320242025
Debt / equity (×)
2022202320242025
EPS ($)
-$5.51 -$0.81 -$0.78 -$0.80 2022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022
Return on assets-8.9%-13.6%-18.6%-52.5%
Return on equity-9.3%-14.2%-19.8%44.6%
Current ratio24.8124.7419.147.16

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.